Showing posts with label Schizophrenia. Show all posts
Showing posts with label Schizophrenia. Show all posts
Saturday, June 14, 2025

FDA Approves Mezofy (aripiprazole) Oral Film for the Treatment of Schizophrenia

›
In continuation of my update on Aripiprazole CMG Pharmaceuticals, an affiliate of Cha Biotech, announced on the 16th that it had received pr...
Tuesday, August 6, 2024

Blood Test to Predict Schizophrenia Shows Promise

›
Researchers say they have developed a blood test for schizophrenia. More than 3 million people in the United States have schizophrenia, a di...
Tuesday, May 3, 2022

FDA Approves Igalmi (dexmedetomidine) Sublingual Film for Acute Treatment of Agitation Associated with Schizophrenia or Bipolar I or II Disorder in Adults

›
BioXcel Therapeutics, Inc., a biopharmaceutical company utilizing artificial intelligence (AI) approaches to identify and develop transforma...
Thursday, November 28, 2019

FDA Approves Secuado (asenapine) Transdermal System for the Treatment of Adults with Schizophrenia

›
Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced the U.S. Food and Drug Admin...
Tuesday, October 23, 2018

FDA Approves Perseris (risperidone) for Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults

›
In continuation of my update on  risperidone Indivior PLC,   announced that the U.S. Food and Drug Administration (FDA) has approved...